p53 Mutation, Murine Double Minute 2 Amplification, and Human Papillomavirus Infection Are Frequently Involved but not Associated with Each Other in Esophageal Squamous Cell Carcinoma

Clinical Cancer Research

Volumn 1, Issue 7, 1995, Pages 769-773

  Shibagaki, Ichio ^a   Tanaka, Hisashi ^a,b   Shimada, Yutaka ^a   Wagata, Takashi ^a   Ikenaga, Mituo ^a   Imamura, Masayuki ^a   Ishizaki, Kanji ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DOUBLE MINUTE CHROMOSOME; ESOPHAGUS CARCINOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

AMINO ACID SUBSTITUTION; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GENE AMPLIFICATION; GENES, P53; HUMAN; INTRONS; NEOPLASM PROTEINS; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS; VIRUS INTEGRATION;

EID: 0029033840     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nishihira, T., Hashimoto, Y., Katayama, M., Mori, S., and Kuriki, T. Molecular and cellular features of esophageal cancer cells. J. Cancer Res. Clin. Oncol., 119: 441–449, 1993
2. Jiang, W., Kahn, S. M., Tomita, N., Zhang, Y-J., Lu, S-H., and Weinstein, B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52: 2980–2983, 1992.
3. Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, R., and Harris, C. C. Frequent mutation of p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958–9961, 1990.
4. Wagata, T., Shibagaki, I., Imamura, M., Shimada, Y., Toguchida, J., Yandell, D. W., Ikenaga, M., Tobe, T., and Ishizaki, K. Loss of 17p, mutation of p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res., 53: 846–850, 1993.
5. Shibagaki, I., Shimada, Y., Wagata, T., Ikenaga, M., Imamura, M., and Ishizaki, K. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res., 54: 2996–3000, 1994.
6. Bennett, W. P., Hollstein, M. C., Metcalf, R. A., Welsh, J. A., He, A., Zhu, S., Kusters, I., Resau, J. H., Trump, B. F., Lane, D. P., and Harris, C. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res., 52: 6092–6097, 1992.
7. Wang, L-D., Hong, J-Y., Qin, S-L., Gao, H., and Yang, C. S. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res., 53: 1783–1787, 1993.
8. Gao, H., Wang, L-D., Zhou, Q., Hong, J-Y., Haung, T-Y., and Yang, S. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res., 54: 4342–4346, 1994.
9. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237–1245, 1992.
10. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. Amplification of gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 358: 80–83, 1992.
11. Leach, F. S., Tokino, T., Meltzer, P., Burrell, J., Oliner, J. D., Smith, S., Hill, D. E., Sidransky, D., Kinzler, K. W., and Vogelstein, B. p53 mutations and MDM2 amplification in human soft tissue sarcomas. Cancer Res., 53: 2231–2234, 1993.
12. Sheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell, 63: 1129–1136, 1990.
13. zur Hausen, H. Papillomaviruses in human cancer. Appl. Pathol., 5: 19–24, 1987.
14. Togawa, K., Jaskiewicz, K., Takahashi, H., Meltzer, S. J., and Rustgi, A. K. Human papillomavirus DNA sequence in esophageal squamous cell carcinoma. Gastroenterology, 107: 128–136, 1994.
15. Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N., and Tobe, T. Characterization of twenty-one newly established esophageal cancer cell lines. Cancer (Phila.), 69: 277–284, 1991.
16. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, pp. 382–389. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
17. Toguchida, T., Yamaguchi, T., Ritchie, B., Beauchamp, R. L., Dayton, S. H., Herrera, G. E., Yamamuro, T., Kotoura, Y., Sasaki, S. M., Little, J. B., Weichselbaum, R. P., Ishizaki, K., and Yandell, W. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res., 52: 6194–6199, 1992.
18. Yandell, D. W., Campbell, T. A., Peterson, R., Walton, D., Little, J. B., McConkie-Rosell, A., Buckley, E. D., and Dryja, T. P. Oncogenic point mutation in the human retinoblastoma gene: their application to genetic counseling. N. Engl. J. Med., 321: 1689–1695, 1989.
19. Fujinaga, Y., Shimada, M., Okazawa, K., Fukushima, M., Kato, I., and Fujinaga, K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J. Gen. Virol., 72: 1039–1044, 1991.
20. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E., and Collins, V. Amplification and overexpression of the MDM2 gene in subset of human malignant gliomas without p53 mutations. Cancer Res., 53: 2736–2739, 1993.
21. Esteve, A., Lehman, T., Jiang, W., Weinstein, B., Harris, C. C., Ruol, A., Peracchia, A., Montesano, R., and Hollstein M. Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in esophageal carcinomas. Mol. Carcinog., 8: 306–311, 1993.
22. Kulski, J., Demeter, T., Sterrett, G. F., and Shilkin, K. B. Human papillomavirus DNA in esophageal carcinoma. Lancet, 2: 683–684, 1986.
23. Furihata, M., Ohtsuji, Y., Ogoshi, S., Takahashi, A., Tamiya, T., and Ogata, T. Prognostic significance of human papillomavirus genomes (type-16,-18) and aberrant expression of p53 protein in human esophageal cancer. Int. J. Cancer, 54: 226–230, 1993.
24. Chang, F., Syranen, S., Shen, Q., Ji, H., and Syranen, K. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinoma from China. Int. J. Cancer, 45: 21–25, 1990.
25. Lee, Y. Y., Wilczynski, S. P., Chumakov, A., Chih, D., and Koeffler, P. Carcinoma of the vulva: HPV and p53 mutations. Oncogene, 9: 1655–1659, 1994.